Back to search

Peptide record

TPDB10173

Antibacterial Anticancer Hemolysis Toxicity standard
23 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB10173
Antibacterial Anticancer Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 Peptipedia HemoPI Hemolytic2 PD_Hemolysis ToxinPred 3.0
standard
No
A 23-aa standard natural multi-activity (Antibacterial, Anticancer, Hemolysis, and other sources) peptide sequence curated from AntiBP3, Peptipedia, HemoPI, and other sources, with an available 3D structural model.
Sequence
GKLIKKFGRKAISYAVKKARGKH
Physicochemical Analysis
C119H206N38O26
NDCEQMPTW
K
2585.18
11.77
10
0
9
+9
5.98
-0.765
76.52
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
1490
57.64
2
Residue Composition
number
3
A
2
R
0
N
0
D
0
C
0
E
0
Q
3
G
1
H
2
I
1
L
7
K
0
M
1
F
0
P
1
S
0
T
0
W
1
Y
1
V
Amino Acid Distribution
A: 3 R: 2 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 3 H: 1 I: 2 L: 1 K: 7 M: 0 F: 1 P: 0 S: 1 T: 0 W: 0 Y: 1 V: 1
Chemical Descriptors
23
C119H206N38O26
2585.18
11.77
+9
5.98
-0.765
Evidence Records 3 records
Evidence 1 Activity

Activity

50% Hemolysis
Toxicity
>36 µM
Hemolytic Cytotoxic
50% Hemolysis | >36 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
N-terminal amphipathic helix as a trigger of hemolytic activity in antimicrobial peptides: a case study in latarcins. | FEBS Lett | 2009
Evidence 2 Activity

Activity

% Hemolysis
Toxicity
50 %
Hemolytic Cytotoxic
Hemolytic_activity: Human erythrocytes: 50% Hemolysis>36 µM | Cytotoxicity: Not available

Target

erythrocytes

Source & Reference

NA
DRAMP
FEBS Lett. 2009 Jul 21 583(14):2425-8.
Evidence 3 Hemolysis

Source & Reference

HemoPI PD_Hemolysis
PD_Hemolysis